glp-1 receptor agonist fatigue management strategies Application of nutrition interventions with based therapies: A narrative review of the challenges and solutions Pharmacovigilance analysis of neurological adverse
Description
The Blood PressureLowering Effects of Glucagon-Like Peptide-1 Receptor Agonists: A Mini-Review of the Potential Mechanisms
Group, Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study, Lancet, 372 (2008) 12401250
Diagnostic confirmation requires objective demonstration of delayed gastric emptying
Glucagonlike peptide1 receptor activation in the nucleus accumbens core suppresses feeding by increasing glutamatergic AMPA/kainate signaling
